Anti-HER2 Single Domain Antibody 2Rs15d Labeled with 18F Using a Residualizing Label: Preliminary Evaluation

被引:0
|
作者
Vaidyanathan, G. V. [1 ]
Zhou, Z. [1 ]
McDougald, D. [1 ]
Lahoutte, T. [2 ]
Zalutsky, M. R. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Free Univ Brussels, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP594
引用
收藏
页码:S179 / S179
页数:1
相关论文
共 50 条
  • [11] Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic
    Feng, Yutian
    Sarrett, Samantha
    Meshaw, Rebecca
    Vaidyanathan, Ganesan
    Zeglis, Brian
    Zalutsky, Michael
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S32 - S32
  • [12] Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation
    Zhou, Zhengyuan
    Chitneni, Satish K.
    Devoogdt, Nick
    Zalutsky, Michael R.
    Vaidyanathan, Ganesan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 1939 - 1949
  • [13] Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
    Vaidyanathan, Ganesan
    McDougald, Darryl
    Choi, Jaeyeon
    Koumarianou, Eftychia
    Weitzel, Douglas
    Osada, Takuya
    Lyerly, H. Kim
    Zalutsky, Michael R.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 967 - 973
  • [14] Simplified 211At-labeling of internalizing proteins by preconjugation with the tin precursor of a residualizing prosthetic agent: Application to an anti-HER2 single domain antibody fragment
    Kang, Choong Mo
    Vaidyanathan, Ganesan
    McDougald, Darryl
    Zalutsky, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [15] A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities
    Wu, Xiaoqiong
    Chen, Siqi
    Lin, Limin
    Liu, Jiayu
    Wang, Yanlan
    Li, Yumei
    Li, Qing
    Wang, Zhong
    TRANSLATIONAL ONCOLOGY, 2018, 11 (02): : 366 - 373
  • [16] Automated radiofluorination of HER2 single domain antibody: the road towards the clinical translation of [18F]FB-HER2 sdAb
    Dierick, Herlinde
    Navarro, Laurent
    van den Block, Sonja
    Salien, Jelena
    Lahoutte, Tony
    Caveliers, Vicky
    Bridoux, Jessica
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2024, 9 (01)
  • [17] Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool
    Sawmynaden, Kovilen
    Wong, Nicholas
    Davies, Sarah
    Cowan, Richard
    Brown, Richard
    Tang, David
    Henry, Maud
    Tickle, David
    Matthews, David
    Carr, Mark
    Bakrania, Preeti
    Ting, Hong Hoi
    Hall, Gareth
    PLOS ONE, 2023, 18 (07):
  • [18] Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment
    Feng, Yutian
    Meshaw, Rebecca
    Zhao, Xiao-Guang
    Jannetti, Stephen
    Vaidyanathan, Ganesan
    Zalutsky, Michael R.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (01) : 124 - 130
  • [19] Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA
    Tolmachev, Vladimir
    Yim, Cheng-Bin
    Rajander, Johan
    Perols, Anna
    Karlstrom, Amelie Eriksson
    Haaparanta-Solin, Merja
    Gronroos, Tove J.
    Solin, Olof
    Orlova, Anna
    CONTRAST MEDIA & MOLECULAR IMAGING, 2017,
  • [20] Non-invasive visualization of HER2 expression using 68Ga and 177Lu labeled anti-HER2 antibody fragments
    Li, C.
    Li, B.
    Liu, P.
    Wei, Z.
    Chen, X.
    Zhang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S446 - S446